GlyH-101,
N-(2-naphthalenyl)-((3,5-dibromo-2,4-dihydroxyphenyl)methylene)glycine hydrazide,
GlyH-101,
328541-79-3,
GlyH 101,
CHEMBL1221576,
CFTR Inhibitor II, GlyH-101,
EC-000.1907,
N-(2-Naphthalenyl)-((3,5-dibromo-2,4-dihydroxyphenyl)methylene)glycine hydrazide,
CFTR Inhibitor II,
(Naphthalen-2-ylamino)-acetic acid (3,5-dibromo-2,4,-dihydroxy-benzylidene)-hydrazide,
(Naphthalen-2-ylamino)-acetic acid (3,5-dibromo-2,4-dihydroxy-benzylidene)-hydrazide,
N-(2-naphthalenyl)-[(3,5-dibromo-2,4-dihydroxyphenyl)methylene]glycine hydrazide,
N-2-Naphthalenyl-glycine 2-[(3,5-dibromo-2,4-dihydroxyphenyl)methylene]hydrazide,
GlyH - 101,
SCHEMBL12648530,
EX-A2041,
3698AH,
BDBM50324733,
AKOS025148694,
AKOS026750493,
AKOS032947331,
CS-2098,
BC600597,
HY-18336,
S8094,
J-018908,
(Naphthalen-2-ylamino)acetic acid (3,5-dibromo-2,4,-dihydroxybenzylidene)hydrazide,
N''-(3,5-dibromo-2,4-dihydroxybenzylidene)-2-(naphthalen-2-ylamino)acetohydrazide,
N'-(3,5-dibromo-2,4-dihydroxybenzylidene)-2-(naphthalen-2-ylamino)acetohydrazide,
N'-[(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]-2-[(naphthalen-2-yl)amino]acetohydrazide,
N-2-Naphthalenyl-2-[(3,5-dibromo-2,4-dihydroxyphenyl)methylene]glycine hydrazide,
D0S1FV,
-ACETICACID -HYDRAZIDE,
AGN-PC-005HH0,
C19H15Br2N3O3,
CTK8E9894,
CID11260414,
CID 11260414,
B1087,
A13723,
C548779,